Cantor Fitzgerald Upgrades Hyperion DeFi (NASDAQ:HYPD) to “Strong-Buy”

Hyperion DeFi (NASDAQ:HYPD) was upgraded by research analysts at Cantor Fitzgerald to a “strong-buy” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

Other equities analysts have also recently issued reports about the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperion DeFi in a report on Thursday, January 22nd. Chardan Capital set a $7.75 price target on Hyperion DeFi and gave the stock a “buy” rating in a research note on Wednesday, December 24th. Finally, Zacks Research downgraded Hyperion DeFi from a “hold” rating to a “strong sell” rating in a research note on Monday, March 30th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $5.88.

Hyperion DeFi Price Performance

Shares of NASDAQ:HYPD opened at $3.63 on Thursday. Hyperion DeFi has a one year low of $0.89 and a one year high of $17.18. The stock has a fifty day moving average of $3.47 and a 200-day moving average of $4.72. The company has a market capitalization of $41.35 million, a PE ratio of -0.31 and a beta of 2.62. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.68 and a current ratio of 2.68.

Hyperion DeFi (NASDAQ:HYPD) last issued its quarterly earnings results on Thursday, March 26th. The company reported ($7.76) EPS for the quarter. The company had revenue of $0.50 million for the quarter. As a group, equities analysts anticipate that Hyperion DeFi will post -41.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Sanctuary Advisors LLC bought a new stake in shares of Hyperion DeFi during the fourth quarter worth $38,000. Nations Financial Group Inc. IA ADV bought a new position in shares of Hyperion DeFi in the 4th quarter valued at about $40,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Hyperion DeFi during the 4th quarter valued at $73,000. Formidable Asset Management LLC bought a new stake in shares of Hyperion DeFi during the 4th quarter valued at $83,000. Finally, State Street Corp bought a new stake in shares of Hyperion DeFi during the 4th quarter valued at $92,000. 25.84% of the stock is owned by institutional investors.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.